You are using an outdated browser. Please upgrade your browser to view our website properly.


Our Innovation

At Baxter Laboratories, innovation is at the core of our research and development process. We regularly survey the domestic and international markets, in sun care, skin care and topical pharmaceuticals to identify areas which require new or better solutions to meet the consumer’s ever evolving needs. We are committed to ensuring that the latest technologies in raw materials and packaging are fast-tracked to market. By continually thinking of new and creative ways to make formulations more desirable, efficient and effective, it enables us to provide you with products that are a step ahead.

Case Study 1

Baxter Laboratories collaborates with Melbourne-based universities to create an Immune Balance Rating™ (IBR™) for topical Skin Care products.

Baxter Laboratories is the industry-partner, in a major Advanced Manufacturing CRC project with RMIT and Monash University. The research has resulted in the development of a series of in-vitro test methods for assessing immune response in respect of topically applied ingredients and formulations. More specifically, the research relates to a method for determining the potential for an immune system response, including the potential for hypoallergenicity, of topical ingredients, components and formulations. The tests are conducted on human skin cells and immune cells for their likelihood of eliciting an immune system response. Alterations in biomarkers are assessed and measured using a specific quantitative assay. The dose response profile of each test compound can be compared to known reference material. The patent-pending IBR rating comprises 5 criteria or “Product Indicators”. They are: Immunostimulation, Immunosuppression, Phototoxicity, Protection against UV Damage, Protection against UV Immunosupression.

The following table shows the five product indicators and the immune balance rating for topical ingredients, components or formulations using a system based on stars.

The benefits of this test procedure are numerous and include the potential to reduce or eliminate the need for animal testing, minimises formulation costs and optimises formulations and provides evidence-based (dose-response) information to support product claims.

Case Study 2

Baxter Laboratories revolutionises the Sun Care market with its ‘Dry Touch’ and ‘Clear Zinc’ Sunscreen Technology.

Baxter Laboratories developed and launched the ‘Dry Touch’ and Clear Zinc’ Sunscreen technology in Australia in 2007. Using unique technologies and specialised formulation techniques, we are proud to have developed sunscreens which not only provide the highest SPF protection available for the Australia Sun Care market, and the highest level of Water Resistance, but also unique properties for specific market segments. These sunscreen formulations are not only cost competitive, but also present significant differences to current available formulations on the market.

These formulations have been developed for sale globally, and provide attributes that are not available in many of specific regions. Innovation is at the forefront of these formulations, together with our sunscreen business model and philosophy. We develop for the future, utilising not only unique ingredients from our key suppliers, but also innovative formulating techniques that add value aesthetically and also effectively.